Co-Diagnostics, Inc. (CODX) Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

Co-Diagnostics, Inc. Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

Co-Diagnostics, Inc. (CODX) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount of $7.84 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2026-03-31

• Co-Diagnostics, Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2025 was $7.84M, a 2.08% decline from fiscal 2024.
• Co-Diagnostics, Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2024 was $8.00M.
• Co-Diagnostics, Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2020 was -$5.16M, a 510.20% decline from fiscal 2019.
• Co-Diagnostics, Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2019 was $1.26M, a 1.44% decline from fiscal 2018.